Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

ALEMBIC LTD. - 506235 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 of the SEBI Listing Regulations, 2015, we enclose herewith a copy of notice published in English and vernacular language (Gujarati) newspaper on Wednesday, 20th April, 2022 in Indian Express (English Edition) and Financial Express (Gujarati Edition) informing the members inter alia about the completion of dispatch of Notice of Postal Ballot dated 12th April, 2022 and E-voting information, in respect of the Special Resolution for Re-appointment of Mrs. Malika Amin (DIN: 00242613) as Managing Director and Chief Executive Officer of the Company. We request you to kindly take the same on record.
20-04-2022
Bigul

ALEMBIC LTD. - 506235 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayALEMBIC LTD. 2CINL26100GJ1907PLC000033 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Drigesh Mittal Designation: Company Secretary EmailId: drigesh.mittal@alembic.co.in Name of the Chief Financial Officer: Rasesh Shah Designation: CFO EmailId: rasesh.shah@alembic.co.in Date: 20/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
20-04-2022

Alembic gets USFDA nod to market generic drug

 The company has received tentative approval from the US Food Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for lvabradine tablets (5 mg and 7.5 mg), Alembic Pharmaceuticals said in a regulatory filing.
20-04-2022
Bigul

ALEMBIC LTD. - 506235 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 Pursuant to Regulation 30 of the SEBI Listing Regulations, 2015, we hereby enclose a copy of postal ballot notice which is being sent to the equity shareholders holding equity shares of the Company as on cut-off date, being Friday, 15th April, 2022, seeking approval for Re-appointment of Mrs. Malika Amin (DIN: 00242613) as Managing Director and Chief Executive Officer of the Company. The e-voting period shall commence on Thursday, 21st April, 2022 at 9.00 AM (IST) and end on Friday, 20th May, 2022 at 5.00 PM (IST). The voting results along with the Scrutinizer's Report will be announced on or before Monday, 23rd May, 2022. The postal ballot notice is also available on website of Company at www.alembiclimited.com. We request you to kindly take the same on record.
19-04-2022
Bigul

ALEMBIC LTD. - 506235 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the following share certificate(s) of the Company has been reported as lost/misplaced and the shareholder of such lost share certificate(s) has requested the Company for issue of duplicate share certificate(s): Also find attached herewith copy of email received from RTA as a proof of date of receipt of information by the Company. We request you to kindly take the same on record.
13-04-2022

Alembic says it received tentative USFDA nod for its anti-cardiac stroke medicine

 This drug has an estimated market size of $465 million for twelve months ending December 2021
08-04-2022
Bigul

ALEMBIC LTD. - 506235 - Certificate As Per Regulation 40(9) Of SEBI Listing Obligations & Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2022

 With reference to the captioned matter, we enclose herewith Certificate as per Regulation 40 (9) of SEBI Listing Obligations & Disclosure Requirements) Regulations, 2015 for the half year ended 31st March, 2022 issued by M/s. Samdani Shah & Kabra, Practicing Company Secretaries, Vadodara. We request you to kindly take the same on record.
08-04-2022
Bigul

ALEMBIC LTD. - 506235 - Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2022

 With reference to the captioned subject, we hereby confirm that all activities in relation to both physical and electronic share transfer facility are maintained by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is a SEBI approved category-I, Registrar & Transfer Agent, registered with Securities and Exchange Board of India (SEBI Registration Number : INR000004058). We request you to kindly take the same on record.
08-04-2022
Bigul

ALEMBIC LTD. - 506235 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations, 2015")

 Pursuant to Regulation 30 of the Listing Regulations, 2015, please find enclosed herewith a specimen copy of the letter (excluding the annexures) sent to the shareholders holding shares in physical form in compliance with the SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2021/655 dated 3rd November, 2021 read with SEBI Circular No. SEBl/HO/MIRSD/MIRSD_RTAMB/P/CIR/2021/687 dated 14th December, 2021 (collectively referred to as 'SEBI Circulars') requesting them to furnish their PAN, KYC details and Nomination details (including declaration to opt out) to the Registrar and Share Transfer Agent of the Company, i.e., Link Intime India Private Limited. Further, in compliance with the said SEBI Circulars, the Company has also placed the communication / intimation in this regard on its website at https://alembiclimited.com/ We request you to kindly take the same on record.
06-04-2022
Bigul

ALEMBIC LTD. - 506235 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 With reference to the captioned matter, please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2022, received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of our Company. We request you to kindly take the same on record.
05-04-2022
Next Page
Close

Let's Open Free Demat Account